This Circular of Information is an extension of blood and blood component labels that has been prepared jointly by the American Association of Blood Banks, America’s Blood Centers and the American Red Cross.

Required Fact Sheets for Emergency Use Authorization of COVID-19 Convalescent Plasma for Treatment of COVID-19 in hospitalized patients.

• Fact Sheet for Health Care Providers
• Fact Sheet for Patients and Parents/Caregivers

Download a PDF file containing a complete list of active ISBT product codes.

• Product Listing by ISBT Code

The Platelet Bacterial Mitigation Memo provides Versiti’s methods to reduce the risk of bacterial contamination in platelet components.

Each quarter the Versiti Blood Center of Indiana posts a rolling 12 month report on product usage. Download any of the available reports below.

• Product Quality Summary Report - Q1 2020
• Product Quality Summary Report - Q2 2020
• Product Quality Summary Report - Q3 2020
• Product Quality Summary Report - Q4 2020
• Product Quality Summary Report - Q1 2021
• Product Quality Summary Report - Q2 2021
• Product Quality Summary Report - Q3 2021
• Product Quality Summary Report - Q4 2021
• Product Quality Summary Report - Q1 2022

The TRALI Mitigation Policy outlines Versiti's strategy to reduce the risk of TRALI, comply with AABB standards and improve the safety of the blood supply.

Educational materials for healthcare professionals about transfusion and patient blood management

• Aberrant or Discrepant Result Investigations
• Antibodies to High and Low-incidence Antigens
• Auto-Antibodies
• Drug-Dependent Antibodies
• Hemolytic Disease of the Newborn Investigations
• Reagent-Dependent Reactivity
• Single to Complex Multiple Antibodies
• Transfusion Reaction Investigations

• ABO Discrepancies
• Discrepant Red Cell Antigen Typing
• Donor/Patient Red Cell Phenotype and Genotype (Serologic and Molecular testing available)
• Polyagglutination Investigation
• Prenatal Evaluations (ABO/Rh, ABID, titer)
• Weak Antigen Expression Investigations

• Consultation Request Form
• Reference Lab Email Encryption for Final Result
• Reference Lab Tag
• Updated Charge Process

Submitting Samples

To submit a sample for investigation, follow the flowchart or the steps listed below.

1. Draw the sample (view sample requirements)
2. Complete the Indiana Consultation Request Form (updated 09/04/19)
3. Call the Reference Lab at 317-916-5188, option 1, to request a courier to pick up the sample
    

Requesting Rare Units

To request rare antigen negative blood, follow the flowchart, complete the Indiana rare unit request form, or the steps listed below.

1. Call the Reference Lab at 317-916-5188, option 1
2. Speak with the Reference Lab Specialist to arrange for delivery of rare units